THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.

Improving Drug Efficacy with
Next-Generation Amorphous Materials and Trained Experts

What is IDEAS?

IDEAS is a Doctoral Network funded within the framework of the Marie Skłodowska-Curie Actions (MSCA) focused on overcoming one of the major challenges in pharmaceutical development: the poor aqueous solubility of many new drug molecules.

By advancing amorphous pharmaceutical and biopharmaceutical systems, the project aims to improve drug solubility, stability, manufacturability and therapeutic performance.

IDEAS brings together leading academic and industrial partners to train a new generation of researchers able to translate fundamental materials science into practical solutions for the pharmaceutical sector.

The project is scheduled to start on November 1st 2026. Recruitment for the doctoral candidate positions will open soon, so please check the website regularly for updates if you are interested in joining the network as an early-career researcher.

Beneficiaries
0
Associated Partners
0
European Countries
0
Years
0
Million Euros
0
soon-to-be-recruited Doctoral Candidates
0

Objectives

  • Develop next-generation amorphous pharmaceutical and biopharmaceutical materials with improved stability, solubility and dissolution profiles.
  • Advance eco-friendly manufacturing technologies for high-quality amorphous formulations.
  • Bridge fundamental research and industrial development through academic–industry collaboration.
  • Train 15 doctoral candidates with scientific, technical, transferable and innovation-oriented skills.
  • Create long-term training and research capacity in Europe, building on the BioPham ecosystem.

Consortium

This IDEAS consortium brings together leading universities, innovative SMEs and major pharmaceutical partners across Europe, covering the full value chain from inovative formulation design to industrial translation. 

Beneficiaries

Associated partners

Training

This international and intersectoral structure gives doctoral candidates access to complementary expertise, facilities and career perspectives. Through joint supervision, secondments, workshops, and transferable-skills training, IDEAS will prepare researchers to address complex challenges in amorphous pharmaceutical systems and to contribute to Europe’s competitiveness in pharmaceutical research and development.